These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

407 related articles for article (PubMed ID: 33694082)

  • 1. Nanoparticle-mediated pulmonary drug delivery: state of the art towards efficient treatment of recalcitrant respiratory tract bacterial infections.
    Huang Z; Kłodzińska SN; Wan F; Nielsen HM
    Drug Deliv Transl Res; 2021 Aug; 11(4):1634-1654. PubMed ID: 33694082
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Challenges and strategies in drug delivery systems for treatment of pulmonary infections.
    Ho DK; Nichols BLB; Edgar KJ; Murgia X; Loretz B; Lehr CM
    Eur J Pharm Biopharm; 2019 Nov; 144():110-124. PubMed ID: 31493510
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pulmonary Delivery of Emerging Antibacterials for Bacterial Lung Infections Treatment.
    Li J; Zheng H; Leung SSY
    Pharm Res; 2023 May; 40(5):1057-1072. PubMed ID: 36123511
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combination and nanotechnology based pharmaceutical strategies for combating respiratory bacterial biofilm infections.
    Zhang L; Bera H; Wang H; Wang J; Guo Y; Shi C; Cun D; Moser C; Høiby N; Yang M
    Int J Pharm; 2022 Mar; 616():121507. PubMed ID: 35085729
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Advances in pulmonary drug delivery targeting microbial biofilms in respiratory diseases.
    Sharma A; Kumar D; Dahiya K; Hawthorne S; Jha SK; Jha NK; Nand P; Girgis S; Raj S; Srivastava R; Goswami VK; Gregoriou Y; El-Zahaby SA; Ojha S; Dureja H; Gupta G; Singh S; Chellappan DK; Dua K
    Nanomedicine (Lond); 2021 Sep; 16(21):1905-1923. PubMed ID: 34348474
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Challenges and solutions in polymer drug delivery for bacterial biofilm treatment: A tissue-by-tissue account.
    Kasza K; Gurnani P; Hardie KR; Cámara M; Alexander C
    Adv Drug Deliv Rev; 2021 Nov; 178():113973. PubMed ID: 34530014
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A New Era of Pulmonary Delivery of Nano-antimicrobial Therapeutics to Treat Chronic Pulmonary Infections.
    Merchant Z; Buckton G; Taylor KM; Stapleton P; Saleem IY; Zariwala MG; Somavarapu S
    Curr Pharm Des; 2016; 22(17):2577-98. PubMed ID: 26983671
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Emerging strategies in nanotechnology to treat respiratory tract infections: realizing current trends for future clinical perspectives.
    Chen M; Shou Z; Jin X; Chen Y
    Drug Deliv; 2022 Dec; 29(1):2442-2458. PubMed ID: 35892224
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nano-fats for bugs: the benefits of lipid nanoparticles for antimicrobial therapy.
    Thorn CR; Thomas N; Boyd BJ; Prestidge CA
    Drug Deliv Transl Res; 2021 Aug; 11(4):1598-1624. PubMed ID: 33675007
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lipid-based nanomedicines for the treatment of bacterial respiratory infections: current state and new perspectives.
    Arroyo-Urea EM; Lázaro-Díez M; Garmendia J; Herranz F; González-Paredes A
    Nanomedicine (Lond); 2024 Feb; 19(4):325-343. PubMed ID: 38270350
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nanoparticle-based local antimicrobial drug delivery.
    Gao W; Chen Y; Zhang Y; Zhang Q; Zhang L
    Adv Drug Deliv Rev; 2018 Mar; 127():46-57. PubMed ID: 28939377
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nanotechnology-Based Drug Delivery Systems to Control Bacterial-Biofilm-Associated Lung Infections.
    Guo Y; Mao Z; Ran F; Sun J; Zhang J; Chai G; Wang J
    Pharmaceutics; 2023 Nov; 15(11):. PubMed ID: 38004561
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bacteria in the respiratory tract-how to treat? Or do not treat?
    Prat C; Lacoma A
    Int J Infect Dis; 2016 Oct; 51():113-122. PubMed ID: 27776777
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Application of Chitosan and its Derivatives in Nanocarrier Based Pulmonary Drug Delivery Systems.
    Dua K; Bebawy M; Awasthi R; Tekade RK; Tekade M; Gupta G; De Jesus Andreoli Pinto T; Hansbro PM
    Pharm Nanotechnol; 2017; 5(4):243-249. PubMed ID: 28786352
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biofilms and antibiotic therapy: is there a role for combating bacterial resistance by the use of novel drug delivery systems?
    Smith AW
    Adv Drug Deliv Rev; 2005 Jul; 57(10):1539-50. PubMed ID: 15950314
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pulmonary drug delivery: a review on nanocarriers for antibacterial chemotherapy.
    Moreno-Sastre M; Pastor M; Salomon CJ; Esquisabel A; Pedraz JL
    J Antimicrob Chemother; 2015 Nov; 70(11):2945-55. PubMed ID: 26203182
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aerosolized Polymyxin B for Treatment of Respiratory Tract Infections: Determination of Pharmacokinetic-Pharmacodynamic Indices for Aerosolized Polymyxin B against Pseudomonas aeruginosa in a Mouse Lung Infection Model.
    Lin YW; Zhou Q; Onufrak NJ; Wirth V; Chen K; Wang J; Forrest A; Chan HK; Li J
    Antimicrob Agents Chemother; 2017 Aug; 61(8):. PubMed ID: 28559256
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lipid and polymer nanoparticles for drug delivery to bacterial biofilms.
    Forier K; Raemdonck K; De Smedt SC; Demeester J; Coenye T; Braeckmans K
    J Control Release; 2014 Sep; 190():607-23. PubMed ID: 24794896
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mesoporous silica nanoparticles for pulmonary drug delivery.
    García-Fernández A; Sancenón F; Martínez-Máñez R
    Adv Drug Deliv Rev; 2021 Oct; 177():113953. PubMed ID: 34474094
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhaled anti-infective chemotherapy for respiratory tract infections: successes, challenges and the road ahead.
    Velkov T; Abdul Rahim N; Zhou QT; Chan HK; Li J
    Adv Drug Deliv Rev; 2015 May; 85():65-82. PubMed ID: 25446140
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.